Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
The plant is scheduled to come on stream in September 2024
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
No new studies have been requested
It is an application to automate statistical analysis and reporting for clinical research.
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
It paves the way for an industry Code of Good Practice
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Air purification system achieves Intertek zero ozone certification
Subscribe To Our Newsletter & Stay Updated